Abstract
Real-world survival of patients treated with taxane therapy after exposure to immunotherapy and platinum-based chemotherapy for advanced non-small-cell lung cancer without actionable mutations
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have